Log In
Print
BCIQ
Print
Print this Print this
 

GM-CT-01 (formerly Davanat)

  Manage Alerts
Collapse Summary General Information
Company Galectin Therapeutics Inc.
DescriptionGalectin-3 (LGALS3) and LGALS1 inhibitor
Molecular Target Galectin-3 (LGALS3) ; Galectin-1 (LGALS1)
Mechanism of ActionGalectin-3 antagonist
Therapeutic ModalityMacromolecule: Polysaccharide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today